Communiqu Live
Visit UK Communiqué Site by clicking on the UK flag
 On This Site
News
Features
Case Studies
Agency Profiles
Listing
Search
Who's who
Who's where
Other Useful Stuff
Links
Media Information
Subscriptions
Archive
Register
Contact Us
Home

Allergan in $600 million Botox settlement 02-Sep-2010
Allergan has agreed to pay $375 million to settle criminal charges and $225 million to resolve civil claims as part of a settlement with the US Department of Justice over the company’s US sales and marketing practices related to Botox (onabotulinumtoxinA), which the government maintains the firm was promoting for a number of unapproved uses.
Read more...
US News in Brief, September 2, 2010 02-Sep-2010
Lilly Evista patents upheld
GSK epilepsy drug delayed
Pompe drug wins orphan status
Genentech cancer drug delayed
S-A offers $18.5 bln for Genzyme
Read more...
Novartis wins FDA nod for blood pressure pill 27-Aug-2010
Novartis has won US Food and Drug Administration approval for a high blood pressure therapy called Tekamlo, which is a single-pill combination of the company’s renin inhibitor Tekturna (aliskiren) and the calcium channel blocker amlodipine, which is the active ingredient in Pfizer’s top-selling high blood pressure medication Norvasc
Read more...
J&J’s DePuy recalls devices 27-Aug-2010
Johnson & Johnson’s DePuy Orthopaedics unit is recalling two kinds of hip implants that appear to be linked to the need for a higher number of second procedures known as revision surgeries
Read more...
AARP reports drugs price increase 2009 26-Aug-2010
Retail prices for popular brand name drugs “skyrocketed” by more than eight percent last year in spite of a negative general inflation rate, according to AARP
Read more...
Leader of the pack 26-Aug-2010
A human pyramid Being a leader can be tough work in challenging times
Read more...
US News in Brief, August 26, 2010 26-Aug-2010
Cephalon CEO on leave
Stem cell ruling will be appealed
P&G to co-promote sleep drug
EpiCept Ceplene NDA rejected
Pfizer lung cancer study disappoints
FDA advisors back expanded Cymbalta use
Jazz drug nixed by FDA advisors
Read more...
Bill would increase FDA recall powers 06-Aug-2010
New legislation has been introduced in the Senate that would give the US Food and Drug Administration the authority to force companies to recall drugs in cases in which the products have been found to be contaminated or unsafe
Read more...
US News in Brief, August 6, 2010 06-Aug-2010
Study suggests bias in industry research
FDA lifts hold on stem-cell trial
New flu shots approved
GSK forms two new drug partnerships
New recommendations on FDA device reviews 
Read more...
US News in Brief, July 30, 2010 30-Jul-2010
FDA clears Daiichi hypertension drug
Merck Serono MS pill wins priority review
Astellas and Regeneron extend deal
Counterfeit medicines summit
FDA approves drug for drooling
Read more...
Page  1 2 3 Next page

 Top
Communiqué Consultancy

Terms & Conditions | Contact Us | Bookmark This Page | Report Error
Copyright © 2003 Pharmaceutical Marketing Ltd       Design & Development by MSO.net